.png)
SummaryControlled drugs, in German Betaeubungsmittel or BTM, are among the most tightly regulated medicines on the German market. For pharmacies, wholesalers and manufacturers, handling them correctly is as much a data problem as a legal one: the BTM status of a product determines how it may be ordered, prescribed, dispensed and documented.
Two instruments govern controlled substances in Germany. The Betaeubungsmittelgesetz (BtMG) defines which substances count as controlled and lists them in three annexes. The Betaeubungsmittel-Verschreibungsverordnung (BtMVV) regulates how they may be prescribed and dispensed.
Annex III medicines require the official BtM-Rezept, a numbered form issued to prescribers. Pharmacies must record every movement, keep the documentation for the statutory period and reconcile stock. Errors are not only a compliance risk, they can trigger reimbursement problems.
To handle controlled drugs correctly at scale, you need to read the BTM status of a product from its master data, not from memory. In German article master data, each package identified by its PZN carries flags for its regulatory status, including whether it is a controlled substance and under which annex it falls. Reliable, current master data lets warehouse and pharmacy systems apply the right ordering, prescription and documentation rules automatically.
pharmazie.com bundles the German ABDA article master data together with more than 25 other databases in one search, so BTM status can be checked alongside prices, package information and availability. See also our glossary entries on Betaeubungsmittel (BTM) and the T-Rezept, which is a separate special prescription and should not be confused with the BtM-Rezept.
